Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07141277 · ClinicalTrials.gov registry record
GRANITE: Airsupra Effectiveness in the Real World
A clinical trial of Asthma, sponsored by AstraZeneca.
- Recruiting
- Registry status
- 4,000
- Enrollment target
- 1
- Study location
NCT07141277 is a study of Asthma that is actively recruiting participants, run by AstraZeneca. The registered enrollment target is 4,000 participants, above the 1,553-participant average among 374 other Asthma trials with a reported enrollment target (158% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07141277, a study of Asthma, is actively recruiting participants, sponsored by AstraZeneca.
- RECRUITING
- Registry status
- 4,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The GRANITE study aims to evaluate the effectiveness of Airsupra versus albuterol in reducing asthma exacerbation risk in a real-world US population.
Conditions Studied
Interventions
- OTHER None (Observational study)
Study Locations (1)
Delaware
- AstraZeneca - Wilmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2025-07-09 |
| Est. Completion | 2026-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07141277
The ClinicalTrials.gov registry entry for NCT07141277 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,553-participant average among 374 other Asthma trials with a reported enrollment target (158% higher). The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which None (Observational study) is the first listed.
NCT07141277 reports 1 study location spanning 1 distinct geographic area - top geographies include Delaware.
Frequently Asked Questions
What is clinical trial NCT07141277 about?
NCT07141277 is a clinical study titled "GRANITE: Airsupra Effectiveness in the Real World". The GRANITE study aims to evaluate the effectiveness of Airsupra versus albuterol in reducing asthma exacerbation risk in a real-world US population.
What is the current status of trial NCT07141277?
This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 2025-07-09. Estimated completion is 2026-06-30.
What conditions does trial NCT07141277 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT07141277?
The interventions under investigation include: None (Observational study) (OTHER).
Who is sponsoring clinical trial NCT07141277?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07141277 being conducted?
This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Innate Immunity in Allergic Asthma
RECRUITING
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
RECRUITING
-
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RECRUITING · Phase 3
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.